Standard Biotools (LAB) Short-term Investments (2016 - 2025)
Standard Biotools (LAB) has disclosed Short-term Investments for 14 consecutive years, with $66.7 million as the latest value for Q4 2025.
- Quarterly Short-term Investments fell 47.12% to $66.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $66.7 million through Dec 2025, down 47.12% year-over-year, with the annual reading at $66.7 million for FY2025, 47.12% down from the prior year.
- Short-term Investments for Q4 2025 was $66.7 million at Standard Biotools, up from $65.5 million in the prior quarter.
- The five-year high for Short-term Investments was $175.2 million in Q1 2024, with the low at $40.9 million in Q1 2023.
- Average Short-term Investments over 4 years is $100.0 million, with a median of $95.8 million recorded in 2022.
- The sharpest move saw Short-term Investments tumbled 60.63% in 2023, then skyrocketed 328.7% in 2024.
- Over 4 years, Short-term Investments stood at $84.5 million in 2022, then dropped by 25.2% to $63.2 million in 2023, then surged by 99.63% to $126.1 million in 2024, then crashed by 47.12% to $66.7 million in 2025.
- According to Business Quant data, Short-term Investments over the past three periods came in at $66.7 million, $65.5 million, and $78.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.